Article
DNA Methylation–Targeted Drugs
1 Sept 2017
Abstract excerpt
Targeting DNA hypermethylation, using nucleoside analogs, is an efficient approach to reprogram cancer cell epigenome leading to reduced proliferation, increased differentiation, recognition by the immune system, and ultimately cancer cell death. DNA methyltransferase inhibitors have been approved for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myelogenous leukemia. To...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
